Shien Chow

2PUBLICATIONS
13CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Sep 10, 2024
Lenvatinib plus pembrolizumab for untreated advanced renal cell carcinoma: a systematic review and cost-effectiveness analysis.

Nigel Fleeman, Rachel Houten, Sarah Nevitt

|Oct 26, 2016
High-dose interleukin2 - a 10-year single-site experience in the treatment of metastatic renal cell carcinoma: careful selection of patients gives an excellent outcome.

S Chow, V Galvis, M Pillai

Pageof 1

Frequent Collaborators

1 joint publications

Nigel Fleeman

1 joint publications

Rachel Houten

1 joint publications

Sarah Nevitt

1 joint publications

James Mahon